Mail

UK markets close in 1 hour 25 minutes

FTSE 100
8,132.87
+54.01(+0.67%)
FTSE 250
19,814.19
+212.21(+1.08%)
AIM
755.46
+2.34(+0.31%)
GBP/EUR
1.1677
+0.0021(+0.18%)
GBP/USD
1.2507
-0.0004(-0.03%)
Bitcoin GBP
51,499.49
+869.68(+1.72%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Spero Therapeutics, Inc. (SPRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

1.4500

+0.0200

(+1.40%)

As of 09:58AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	77.07M
Enterprise value	6.28M
Trailing P/E	3.33
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.78
Price/book (mrq)	0.72
Enterprise value/revenue	0.06
Enterprise value/EBITDA	0.24

Trading information

Stock price history

Beta (5Y monthly)	0.57
52-week change ³	-19.21%
S&P500 52-week change ³	21.08%
52-week high ³	1.9950
52-week low ³	0.9900
50-day moving average ³	1.6313
200-day moving average ³	1.3966

Share statistics

Avg vol (3-month) ³	324.06k
Avg vol (10-day) ³	230.47k
Shares outstanding ⁵	53.89M
Implied shares outstanding ⁶	54.27M
Float ⁸	39.8M
% held by insiders ¹	20.37%
% held by institutions ¹	26.08%
Shares short (15 Apr 2024) ⁴	513.16k
Short ratio (15 Apr 2024) ⁴	1.62
Short % of float (15 Apr 2024) ⁴	1.16%
Short % of shares outstanding (15 Apr 2024) ⁴	0.95%
Shares short (prior month 15 Mar 2024) ⁴	613.85k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	21.98%
Operating margin (ttm)	68.73%

Management effectiveness

Return on assets (ttm)	10.90%
Return on equity (ttm)	24.95%

Income statement

Revenue (ttm)	103.78M
Revenue per share (ttm)	1.97
Quarterly revenue growth (yoy)	55.00%
Gross profit (ttm)	N/A
EBITDA	27.15M
Net income avi to common (ttm)	22.81M
Diluted EPS (ttm)	0.4300
Quarterly earnings growth (yoy)	91.20%

Balance sheet

Total cash (mrq)	76.33M
Total cash per share (mrq)	1.42
Total debt (mrq)	5.54M
Total debt/equity (mrq)	5.19%
Current ratio (mrq)	3.53
Book value per share (mrq)	2.02

Cash flow statement

Operating cash flow (ttm)	-32.99M
Levered free cash flow (ttm)	-9.9M